ClinicalTrials.Veeva

Menu

Registry of Hospitalized Patients in University Hospital Dubrava Respiratory Center (COVID-19)

U

University Hospital Dubrava

Status

Active, not recruiting

Conditions

Mechanical Ventilation Complication
Thrombosis
Inflammatory Response
Covid19
Sepsis
Bleeding

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT05151094
2021/2503-04

Details and patient eligibility

About

Aim of this project is to understand clinical features, clinical outcomes and efficacy and safety profiles of different therapies by analyzing a cohort of COVID-19 patients hospitalized and treated in a tertiary-level institution, University hospital Dubrava. Patients' clinical and laboratory characteristics, drug exposure and outcomes are obtained by analysis of written and electronical medical records.

Full description

University Hospital Dubrava has been completely repurposed during the COVID-19 pandemic to become high volume COVID-19 tertiary institution. Establishment of hospital registry project is necessary to properly understand disease characteristic, related outcomes and real-life treatment patterns. Registry provides a fundamental framework for future upgrading with emerging or retrogradely obtained specific data that will substantially facilitate understanding of COVID-19 in the context of other specific diseases, therapies and procedures. Large comprehensive database will provide sufficient statistical power to allow for investigation of large number of subgroups and existence of interactions between different variables. Assessment of large number of clinically important outcomes (mortality, occurrence of venous and arterial thromboses, major bleeding, bacteriemia, incidence of mechanical ventilation and intensive care unit admission) is necessary to put any investigated parameter in the proper efficacy and safety context.

Enrollment

6,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all hospitalized patients positive for COVID-19

Exclusion criteria

  • none

Trial design

6,000 participants in 1 patient group

Remdesivir exposure
Description:
Patients treated with remdesivir due to the COVID-19 infection
Treatment:
Other: Observation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems